ANN ARBOR - Esperion Therapeutics, which is developing new therapies to treat high cholesterol that can be taken as a pill, announced it has completed a $33 million preferred stock financing led by new investor Longitude Capital. Existing investors Aisling Capital, Alta Partners, Domain Associates, Arboretum Ventures and Asset Management also participated in the financing.
LANSING - ModuleMD has partnered with Great Lake Health Information Exchange to create a strategic alliance to electronically connect physician practices with health care systems. Health Information Exchange provides the capability of sharing clinical information electronically among disparate electronic health record systems. ModuleMD provides a flexible electronic health record to independent physician practices nationally. Based
ANN ARBOR ? The U.S. Food and Drug Administration has approved the Phase II clinical trail of the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig's disease. Approval paves the way for UM to become the second
ANN ARBOR - Blaze Medical Devices has added two new members to its advisory board, CPA Paul Glantz and finance professional Terry Cross. Blaze is a medical device company focusing on increasing the efficacy and safety of transfusions while reducing transfusion-related costs and reducing the use of blood. Blood units differ in properties based on
MIDLAND - The MidMichigan Innovation Center and BlueWater Angels along with the Office for Innovation at Covenant HealthCare will be co-hosting a health technology forum April 10 to showcase five new Michigan companies - each company having potential to dramatically impact the future of medicine. One of the roles of the Covenant HealthCare Office for
ANN ARBOR ? The next BioArbor on April 10 will feature two seasoned venture capital investors, both with capital to invest and novel investment strategies. Both are based outside of Michigan, yet have made local investments and are actively seeking opportunities to invest in Michigan. The event will offer a great platform to hear about
GRAND RAPIDS - Van Andel Institute is be featured April 4 and later in the month as the Cause of the Day button on AOL.com, which is visited by nearly 15 million people daily. AOL provides an opportunity to educate consumers and connect them with non-profit organizations that are on a mission to change the
LANSING - The Michigan Biotechnology Institute and Michigan State University have entered into a new collaborative arrangement, under which promising bio-based technologies will be accelerated from the laboratory to commercial deployment. The agreement combines MSU?s research expertise with MBI?s ?derisking? process and advanced bioprocessing to quickly and efficiently demonstrate the market-readiness of new technologies. Intellectual
LANSING - Some two-thirds of National Federation of Independent Business-Michigan members do not want to see the state expand Medicaid eligibility, the group announced Thursday. Small business owners feared the plan would end up costing the state in the end, NFIB State Director Charlie Owens said. "The governor and his team deserve credit for trying
ANN ARBOR - Aastrom Biosciences Inc. announced Wednesday that it has named Dominick Colangelo president and CEO. Dan Orlando, who had been interim CEO of Aastrom since November, will continue as chief commercial officer. Orlando replaced had replaced Tim Mayleben. Colangelo has more than 20 years of experience in the pharmaceutical industry, including almost 10